Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction

Don Hayes, Mark Galantowicz, Andrew R. Yates, Thomas J. Preston, Heidi - Mansour, Patrick I. McConnell

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO2/FIO2 (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.

Original languageEnglish (US)
Pages (from-to)382-385
Number of pages4
JournalJournal of Artificial Organs
Volume16
Issue number3
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Primary Graft Dysfunction
Transplants
Extracorporeal Membrane Oxygenation
Oxygenation
Grafts
Lung Transplantation
Membranes
Lung
Transplantation (surgical)
Cystic Fibrosis
Therapeutics

Keywords

  • Cystic fibrosis
  • Lung transplantation
  • Preventative
  • Primary graft dysfunction
  • Protective
  • Venovenous extracorporeal membrane oxygenation

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Cardiology and Cardiovascular Medicine
  • Medicine (miscellaneous)

Cite this

Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction. / Hayes, Don; Galantowicz, Mark; Yates, Andrew R.; Preston, Thomas J.; Mansour, Heidi -; McConnell, Patrick I.

In: Journal of Artificial Organs, Vol. 16, No. 3, 2013, p. 382-385.

Research output: Contribution to journalArticle

Hayes, Don ; Galantowicz, Mark ; Yates, Andrew R. ; Preston, Thomas J. ; Mansour, Heidi - ; McConnell, Patrick I. / Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction. In: Journal of Artificial Organs. 2013 ; Vol. 16, No. 3. pp. 382-385.
@article{2c4038290fa64bb88028b7206daedf63,
title = "Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction",
abstract = "Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO2/FIO2 (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.",
keywords = "Cystic fibrosis, Lung transplantation, Preventative, Primary graft dysfunction, Protective, Venovenous extracorporeal membrane oxygenation",
author = "Don Hayes and Mark Galantowicz and Yates, {Andrew R.} and Preston, {Thomas J.} and Mansour, {Heidi -} and McConnell, {Patrick I.}",
year = "2013",
doi = "10.1007/s10047-013-0699-z",
language = "English (US)",
volume = "16",
pages = "382--385",
journal = "Journal of Artificial Organs",
issn = "1434-7229",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction

AU - Hayes, Don

AU - Galantowicz, Mark

AU - Yates, Andrew R.

AU - Preston, Thomas J.

AU - Mansour, Heidi -

AU - McConnell, Patrick I.

PY - 2013

Y1 - 2013

N2 - Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO2/FIO2 (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.

AB - Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO2/FIO2 (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.

KW - Cystic fibrosis

KW - Lung transplantation

KW - Preventative

KW - Primary graft dysfunction

KW - Protective

KW - Venovenous extracorporeal membrane oxygenation

UR - http://www.scopus.com/inward/record.url?scp=84885422894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885422894&partnerID=8YFLogxK

U2 - 10.1007/s10047-013-0699-z

DO - 10.1007/s10047-013-0699-z

M3 - Article

C2 - 23508264

AN - SCOPUS:84885422894

VL - 16

SP - 382

EP - 385

JO - Journal of Artificial Organs

JF - Journal of Artificial Organs

SN - 1434-7229

IS - 3

ER -